![](https://endpts.com/wp-content/uploads/2021/05/endpts_weekly_FI@x2.jpg)
A $5B Pfizer buyout? Amgen, Gilead headline M&A Thursday; Alnylam's ATTR sweep; Andrew Lo's rare disease quest; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.